Ciro Iaccarino
Via Vienna 2
Sassari, 07100, Italy
Sassari, 07100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Design, anticancer activity, and mechanistic evaluation of a novel class of selective human carbonic anhydrase IX inhibitors featuring a trifluorodihydroxypropanone pharmacophore.
Journal: European journal of medicinal chemistry
Published: June 18, 2025
LRRK2 in Drosophila Melanogaster Model: Insights into Cellular Dysfunction and Neuroinflammation in Parkinson's Disease.
Journal: International journal of molecular sciences
Published: January 22, 2025
Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 Drosophila Models.
Journal: Biomedicines
Published: June 05, 2024
Evaluation of cyanotoxin L-BMAA effect on α-synuclein and TDP43 proteinopathy.
Journal: Frontiers in immunology
Published: December 22, 2023
Inhibition of the Exocyst Complex Attenuates the LRRK2 Pathological Effects.
Journal: International journal of molecular sciences
Published: June 09, 2023
Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: Dangerous Liaisons.
Journal: International journal of molecular sciences
Published: July 12, 2021
Parkinson's Disease-Related Genes and Lipid Alteration.
Journal: International journal of molecular sciences
Published: June 04, 2021
LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8.
Journal: Cells
Published: October 28, 2020
The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity.
Journal: The Journal of cell biology
Published: October 12, 2020
HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo.
Journal: Cell death & disease
Published: September 06, 2019
Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype.
Journal: Journal of cellular and molecular medicine
Published: April 18, 2019
Last Updated: 09/26/2026